Health-tech startup myota, which develops data-driven, microbiome-motivated fibre mixes and a digital health platform, has secured $4.5M in a Series A funding round. The investment was provided by PeakBridge.
Myota's offerings are designed to improve overall well-being and prevent chronic disease, leveraging insights from the human microbiome. The company's approach combines personalized nutritional solutions with digital health tools.















